GBP7.41
2.07% today
London, Apr 01, 05:30 pm CET
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Indivior Stock price

GBP7.39
-0.15 1.92% 1M
+0.12 1.65% 6M
-2.85 27.83% YTD
-9.55 56.38% 1Y
-6.86 48.14% 3Y
+5.21 238.53% 5Y
-2.00 21.27% 10Y
London, Closing price Tue, Apr 01 2025
+0.14 1.86%
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Key metrics

Market capitalization GBP904.38m
Enterprise Value GBP948.30m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 173.05
EV/Sales (TTM) EV/Sales 1.02
P/S ratio (TTM) P/S ratio 0.97
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 5.76%
Revenue (TTM) Revenue GBP929.64m
EBIT (operating result TTM) EBIT GBP218.55m
Free Cash Flow (TTM) Free Cash Flow GBP5.48m
Cash position GBP255.51m
EPS (TTM) EPS GBP-0.21
P/E forward 7.53
P/S forward 1.17
EV/Sales forward 1.23
Short interest 348.00%
Show more

Is Indivior a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Indivior Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Indivior forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Indivior forecast:

Buy
100%

Financial data from Indivior

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
930 930
6% 6%
100%
- Direct Costs 192 192
18% 18%
21%
768 768
7% 7%
83%
- Selling and Administrative Expenses 434 434
27% 27%
47%
- Research and Development Expense 85 85
2% 2%
9%
241 241
519% 519%
26%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 219 219
1,226% 1,226%
24%
Net Profit -29 -29
790% 790%
-3%

In millions GBP.

Don't miss a Thing! We will send you all news about Indivior directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Head office United Kingdom
CEO Joseph Ciaffoni
Employees 1,051
Founded 2014
Website indivior.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today